Seniors with diabetes may get more aggressive Tx than recommended

Insulin and sulfonylureas are the second-most-common drugs that drive emergency department visits or admissions and adverse events in diabetes patients ages 65 and older, according to a study in JAMA Internal Medicine. Rese...


This news summary appeared in DiabetesPro SmartBrief on 07/01/2014
Click here to view the full issue.

View the original article:
The New York Times (free-article access for SmartBrief readers)

Want to see more news summaries?
Sign up for DiabetesPro SmartBrief

DiabetesPro SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news summaries like the one to the left
Sign up:
About SmartBrief
SmartBrief is the leading online publisher of targeted business news and information by industry. By combining technology and editorial expertise, SmartBrief filters thousands of sources daily to deliver the most relevant industry news in partnership with more than 180 trade associations, professional societies nonprofits and corporate entities